Physician profile
Bethany A Jackson
NPI 1750517835
$90,455.90
in general payments reported to CMS, 2019-2025
55 companies · $5,042 in 2025
The $5,042 reported for 2025 was more than what 87% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $37K · 2021: $3,794 · 2022: $4,753 · 2023: $4,129 · 2024: $5,514 · 2025: $5,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $2,511 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400 · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,647.27 |
| Travel and Lodging | $2,510.56 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
| Education | $127.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $37,580.96 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Tandem Diabetes Care, INC. | $27,384.79 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $2,947.15 | 2021-2025 | Minimed 780g, Intellis Adaptivestim, Minimed 770g |
| Lilly USA, LLC | $2,831.51 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Sanofi-Aventis U.S. LLC | $2,366.70 | 2019-2025 | |
| Insulet Corporation | $2,111.08 | 2019-2025 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $2,060.62 | 2019-2023 | Farxiga |
| Senseonics, Incorporated | $1,569.00 | 2019-2024 | Eversense |
| Abbott Laboratories | $1,418.38 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,215.75 | 2019-2025 | Jardiance, Synjardy, Trijardy Xr |
| Abbvie INC. | $1,045.48 | 2019-2025 | |
| Corcept Therapeutics | $1,039.81 | 2019-2025 | Korlym |
| Dexcom, INC. | $870.10 | 2020-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Xeris Pharmaceuticals, INC. | $856.93 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Ibsa Pharma INC. | $484.17 | 2019-2025 | Licart, Tirosint, Tirosint |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $464.64 | 2019-2025 | Evenity, Tepezza, Prolia |
| Novartis Pharmaceuticals Corporation | $430.55 | 2023-2024 | |
| Amarin Pharma, INC. | $348.58 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $344.25 | 2021-2025 | |
| Medtronic Minimed, INC. | $324.74 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $283.74 | 2019-2021 | |
| Beta Bionics, INC. | $270.79 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Horizon Therapeutics Plc | $252.61 | 2020-2022 | |
| Sequel Med Tech, LLC | $241.05 | 2024-2025 | Twiist |
| Glaxosmithkline, LLC. | $179.68 | 2025 | Arexvy, Shingrix |
| Antares Pharma, INC. | $166.08 | 2019-2023 | Nocdurna, Tlando, Xyosted |
| Recordati_rare_diseases_inc. | $142.02 | 2020-2025 | Isturisa, Signifor Lar |
| Pfizer INC. | $138.80 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $131.21 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $95.26 | 2024-2025 | |
| Zealand Pharma US, INC. | $93.80 | 2021-2022 | |
| Ascensia Diabetes Care US INC. | $88.56 | 2023 | |
| Amneal Pharmaceuticals LLC | $49.93 | 2022 | |
| Becton, Dickinson and Company | $45.97 | 2021-2022 | |
| Boston Scientific Corporation | $44.97 | 2024 | Wavewriter Alpha Prime 16 |
| Companion Medical, INC. | $44.83 | 2019-2020 | |
| Chiesi USA, INC. | $44.70 | 2024 | Mycapssa, Myalept |
| Alexion Pharmaceuticals, INC. | $39.90 | 2019-2023 | Strensiq |
| Radius Health, INC. | $34.09 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.59 | 2021 | |
| Phathom Pharmaceuticals, INC. | $31.74 | 2024-2025 | Voquezna |
| Lifescan, INC. | $29.99 | 2019-2020 | |
| Grt US Holding, INC. | $29.68 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $28.24 | 2019 | |
| Rhythm Pharmaceuticals, INC. | $28.11 | 2022 | |
| Shire North American Group INC | $27.57 | 2019 | |
| Ionis Pharmaceuticals, INC. | $24.30 | 2025 | Tryngolza |
| Averitas Pharma INC. | $23.85 | 2025 | Qutenza |
| Ultragenyx Pharmaceutical INC. | $23.85 | 2023 | |
| Ascendis Pharma Endocrinology INC | $18.07 | 2025 | Yorvipath |
| Esperion Therapeutics, INC. | $17.34 | 2024 | Nexletol |
| Kyowa Kirin, INC. | $16.13 | 2024 | Crysvita |
| Tolmar, INC. | $14.87 | 2024 | |
| Soleno Therapeutics, INC. | $13.56 | 2025 | Vykat Xr |
| Sun Pharmaceutical Industries INC. | $12.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.